1. Home
  2. CYTK vs CAG Comparison

CYTK vs CAG Comparison

Compare CYTK & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$75.98

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$13.90

Market Cap

7.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
CAG
Founded
1997
1919
Country
United States
United States
Employees
N/A
26100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
7.5B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
CAG
Price
$75.98
$13.90
Analyst Decision
Strong Buy
Hold
Analyst Count
19
17
Target Price
$89.26
$16.88
AVG Volume (30 Days)
3.0M
12.3M
Earning Date
05-05-2026
04-01-2026
Dividend Yield
N/A
9.84%
EPS Growth
N/A
233.33
EPS
N/A
N/A
Revenue
$13,368,000.00
$1,500,000,000.00
Revenue This Year
$7.37
N/A
Revenue Next Year
$310.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.81
$13.42
52 Week High
$80.20
$23.09

Technical Indicators

Market Signals
Indicator
CYTK
CAG
Relative Strength Index (RSI) 61.72 41.60
Support Level $58.59 $13.82
Resistance Level $80.20 $14.56
Average True Range (ATR) 3.87 0.45
MACD 0.45 0.04
Stochastic Oscillator 80.49 42.73

Price Performance

Historical Comparison
CYTK
CAG

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CAG ConAgra Brands Inc.

Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

Share on Social Networks: